CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,200 | -49.6% | 4,000 | -20.0% | 0.01% | -44.4% |
| Q2 2023 | $18,250 | +2.2% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $17,850 | -63.2% | 5,000 | -70.6% | 0.01% | -67.9% |
| Q4 2022 | $48,450 | +27.5% | 17,000 | 0.0% | 0.03% | +27.3% |
| Q3 2022 | $38,000 | +26.7% | 17,000 | +41.7% | 0.02% | +15.8% |
| Q2 2022 | $30,000 | +50.0% | 12,000 | +200.0% | 0.02% | +90.0% |
| Q1 2022 | $20,000 | -55.6% | 4,000 | 0.0% | 0.01% | -52.4% |
| Q4 2021 | $45,000 | -22.4% | 4,000 | 0.0% | 0.02% | -41.7% |
| Q3 2021 | $58,000 | +23.4% | 4,000 | 0.0% | 0.04% | +24.1% |
| Q2 2021 | $47,000 | -4.1% | 4,000 | 0.0% | 0.03% | -19.4% |
| Q1 2021 | $49,000 | -2.0% | 4,000 | 0.0% | 0.04% | -12.2% |
| Q4 2020 | $50,000 | -16.7% | 4,000 | 0.0% | 0.04% | -30.5% |
| Q3 2020 | $60,000 | – | 4,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |